Eltrombopag Combining Rituximab Versus Eltrombopag in the Management of Primary Immune Thrombocytopenia (ITP) in Adults
Clinical trial NCT04518475 · RECRUITING
Trial details
- NCT number
- NCT04518475
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-10
- Primary completion
- 2029-02-10
- Enrollment
- 224
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.